‘Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally’ -WSJ Report

https://www.wsj.com/articles/monkeypox-outbreak-shows-signs-of-cooling-in-u-s-and-globally-11661526042?mod=e2tw

byBenzinga Newsdesk

August 26, 2022

1 minute read

https://www.wsj.com/articles/monkeypox-outbreak-shows-signs-of-cooling-in-u-s-and-globally-11661526042?mod=e2tw

FDA
News

UPDATE: New York Time Wednesday Reported Cleveland Clinic, Mount Sinai Won’t Administer Biogen’s Aduhelm To Patients

By Benzinga Newsdesk

Today, 11:09 PM

https://www.nytimes.com/2021/07/14/health/cleveland-clinic-aduhelm.html

BIIB

The Thing Behind The Thing: ASML Powering The World’s Semiconductor Companies

By Chris Katje

Today, 11:09 PM

Benzinga routinely examines a stock that might be considered a little under the radar. The company may not be well-known, but chances are the line of work it’s in is pretty familiar. This is called the “thing behind the thing.”

AAPL

B. Riley Securities Maintains Buy on Global Medical REIT, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 11:09 PM

B. Riley Securities analyst Bryan Maher maintains Global Medical REIT (NYSE:GMRE) with a Buy and lowers the price target from $14 to $12.

GMRE

Why These 3 Analysts Are Unimpressed With Ford’s Q2 Beat

By Priya Nigam

Today, 11:09 PM

Ford Motor Company (NYSE: F) crushed Wall Street expectations, with quarterly revenue at $40.2 billion, up 50% year-over-year, and adjusted earnings 68 cents per share, versus a consensus of 45 cents per share. RBC Capital Markets On Ford Motor Company

‘Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally’ -WSJ Report

Related Posts

UPDATE: New York Time Wednesday Reported Cleveland Clinic, Mount Sinai Won’t Administer Biogen’s Aduhelm To Patients

The Thing Behind The Thing: ASML Powering The World’s Semiconductor Companies

B. Riley Securities Maintains Buy on Global Medical REIT, Lowers Price Target to $12

Why These 3 Analysts Are Unimpressed With Ford’s Q2 Beat